3-Phenyl-2-thioxo-1,3-thiazolidin-4-one
暂无分享,去创建一个
[1] Louis J. Farrugia,et al. ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) , 1997 .
[2] M. Sim,et al. Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. , 2001, Bioorganic & medicinal chemistry letters.
[3] L. Costantino,et al. Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. , 2002, Bioorganic & medicinal chemistry.
[4] T. Sohda,et al. Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds. , 1991, Chemical & pharmaceutical bulletin.
[5] E. C. Morgan,et al. Some 3-Substituted Rhodanines , 1956 .
[6] A. Strongin,et al. Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies. , 2006, Journal of medicinal chemistry.
[7] 良二 上田. J. Appl. Cryst.の発刊に際して , 1970 .
[8] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[9] 國郎 小笠原,et al. Chem. Pharm. Bull.(オピニオン) , 2007 .
[10] Anthony L. Spek,et al. Journal of , 1993 .
[11] K. Shimotohno,et al. Novel hepatitis C virus protease inhibitors: thiazolidine derivatives. , 1997, Biochemical and biophysical research communications.